The World Health Organization (WHO)'s decision to give node to China's Sinopharm COVID-19 vaccine will facilitate access to jabs among the struggling African countries that fell victim to vaccine nationalism, according to an African policy expert.
The World Health Organization (WHO)'s decision to give node to China's Sinopharm COVID-19 vaccine will facilitate access to jabs among the struggling African countries that fell victim to vaccine nationalism, according to an African policy expert.
